These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 22289749)

  • 101. Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia.
    Scheinberg P; Nunez O; Young NS
    Br J Haematol; 2006 Jun; 133(6):622-7. PubMed ID: 16704436
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
    Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
    Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.
    Elmahdi S; Muramatsu H; Narita A; Ismael O; Hama A; Nishio N; Okuno Y; Xu Y; Wang X; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2016 Apr; 63(4):659-64. PubMed ID: 26575027
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Immunosupressive therapy of aplastic anemia patients: successes and failures (single center experiment 2007-2016)].
    Mikhaylova EA; Fidarova ZT; Abramova AV; Luchkin AV; Troitskaya VV; Dvirnyk VN; Galtseva IV; Kliasova GA; Kovrigina AM; Kulikov SM; Chabaeva YА; Parovichnikova EN; Savchenko VG; Obukhova TN
    Ter Arkh; 2020 Sep; 92(7):4-9. PubMed ID: 33346440
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
    Chen M; Zhuang J; Zhou D; Xu Y; Zhao Y; Wang S; Zhang W; Duan M; Zhu T; Li J; Cai H; Cao X; Han B
    Ann Hematol; 2017 Apr; 96(4):581-587. PubMed ID: 28084534
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
    Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [Treatment of transfusion-dependent nonsevere aplastic anemia with cyclosporine A plus ATG/ALG versus cyclosporine A plus androgens: a retrospective single center study].
    Song L; Peng GX; Wu ZJ; Zhang L; Jing LP; Zhou K; Li Y; Li Y; Ye L; Li JP; Fan HH; Zhao X; Yang WR; Yang Y; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Nov; 37(11):946-951. PubMed ID: 27995878
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
    Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
    Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Granulocyte colony-stimulating factor-supported combined immunosuppressive therapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) in patients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment.
    Meidlinger P; Knöbl P; Jäger U; Gisslinger H; Pabinger I; Weltermann A; Lechner K; Geissler K
    Ann Hematol; 1999 Jul; 78(7):299-304. PubMed ID: 10466441
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Predicting early response to immunosuppressive therapy in severe aplastic anemia by soluble transferrin receptor assay].
    Yang WR; Xiong YY; Zhang L; Jing LP; Zhou K; Peng GX; Li Y; Ye L; Li Y; Li JP; Fan HH; Song L; Zhao X; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):709-13. PubMed ID: 23978026
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.
    Zhu F; Qiao J; Zhong XM; Wu QY; Chen W; Yao Y; Niu MS; Fu CL; Zeng LY; Li ZY; Xu KL
    Med Oncol; 2015 Jul; 32(7):197. PubMed ID: 26049920
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor.
    Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T
    Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444
    [TBL] [Abstract][Full Text] [Related]  

  • 113. ATG plus cyclosporine reduces all-cause mortality in patients with severe aplastic anemia--systematic review and meta-analysis.
    Gafter-Gvili A; Ram R; Gurion R; Paul M; Yeshurun M; Raanani P; Shpilberg O
    Acta Haematol; 2008; 120(4):237-43. PubMed ID: 19246887
    [TBL] [Abstract][Full Text] [Related]  

  • 114. [Comparison of two types of antithymocyte globulin in the treatment of children with aplastic anemia].
    Xie XT; He W; Shi W; Zhou XX; Qiao XH
    Zhonghua Er Ke Za Zhi; 2016 Apr; 54(4):294-8. PubMed ID: 27055431
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin.
    de-Medeiros CR; Ribeiro RC; Bittencourt MA; Zanis-Neto J; Pasquini R
    Braz J Med Biol Res; 2000 May; 33(5):553-8. PubMed ID: 10775887
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group.
    Locasciulli A; Arcese W; Locatelli F; Di Bona E; Bacigalupo A;
    Lancet; 2001 Jan; 357(9249):43-4. PubMed ID: 11197365
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Aplastic anemia in children: How good is immunosuppressive therapy?
    Jain R; Trehan A; Bansal D; Varma N
    Pediatr Hematol Oncol; 2019 May; 36(4):211-221. PubMed ID: 31287349
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome.
    Kadia TM; Borthakur G; Garcia-Manero G; Faderl S; Jabbour E; Estrov Z; York S; Huang X; Pierce S; Brandt M; Koller C; Kantarjian HM; Ravandi F
    Br J Haematol; 2012 May; 157(3):312-20. PubMed ID: 22360602
    [TBL] [Abstract][Full Text] [Related]  

  • 119. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
    Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
    Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
    [TBL] [Abstract][Full Text] [Related]  

  • 120. High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
    Tisdale JF; Dunn DE; Geller N; Plante M; Nunez O; Dunbar CE; Barrett AJ; Walsh TJ; Rosenfeld SJ; Young NS
    Lancet; 2000 Nov; 356(9241):1554-9. PubMed ID: 11075769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.